Patty McCord, former Chief Talent Officer at Netflix and author of "Powerful: Building a Culture of Freedom and Responsibility", discusses her time at Netflix and why certain principles make the company successful.
McCord discusses her distaste for the word "empower" in the workplace, noting that employees already have power. Executives just need to give it to them.
She digs into the intentionally high turnaround rate at Netflix and why a culture like that is okay. She talks women in the workplace and why equal pay is something that needs to be addressed at this point in time.
Catching you up on what you need to know on April 5, 2022, with Biden's call for a war crimes trial for Putin, another arrest made in the Sacramento mass shooting, NYC rolling out a campaign against Florida’s "Don’t Say Gay" bill, an aluminum shortage potentially affecting beer and cat food cans, and more.
Stocks closed lower on Wall Street Tuesday and bond yields jumped as remarks by a Federal Reserve governor fueled expectations on Wall Street that the central bank is prepared to more aggressively raise interest rates.
Filing your taxes should be easy and straightforward if your documents are together — but what about if you became a new cryptocurrency or retail investor? What if you worked remotely last year, and not in the same state as your employer? What if you received a pandemic stimulus check, or are eligible for the child tax credit? Luis Rivero, CPA and Director of Tax at Taxfyle, joins Closing Bell to discuss what exactly all taxpayers need to know, whether they hold crypto investments, worked out of state, have children, and more.
Two years after the pandemic began, vaccines are widespread, but COVID-19 treatments aren't as plentiful. RedHill Biopharma is working to change that with its easy-to-take coronavirus treatments — which come in pill form and treat cases ranging from mild to severe. Guy Goldberg, Chief Business Officer at RedHill Biopharma, joins Closing Bell to discuss the company's two COVID-19 treatments in trial, pricing once the drugs are widely available, the company's latest earnings results, and more.
